Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine

dc.creatorAbbate, Eduardo
dc.creatorVescovo, Marisa
dc.creatorNatiello, Marcela
dc.creatorCufré, Mónica
dc.creatorGarcía, Ana
dc.creatorGonzalez Montaner, Pablo
dc.creatorAmbroggi, Marta
dc.creatorRitacco, Viviana
dc.creatorvan Soolingen, Dick
dc.date2021-01-05T21:26:36Z
dc.date2021-01-05T21:26:36Z
dc.date2012-02
dc.date.accessioned2023-08-29T20:08:26Z
dc.date.available2023-08-29T20:08:26Z
dc.identifier1460-2091
dc.identifierhttp://sgc.anlis.gob.ar/handle/123456789/2057
dc.identifier10.1093/jac/dkr500
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8520164
dc.descriptionFil: Abbate, Eduardo. Instituto de Tisioneumonología ‘Prof. Dr. Raúl Vaccarezza’, Universidad de Buenos Aires; Argentina.
dc.descriptionFil: Vescovo, Marisa. Instituto de Tisioneumonología ‘Prof. Dr. Raúl Vaccarezza’, Universidad de Buenos Aires; Argentina.
dc.descriptionFil: Natiello, Marcela. Instituto de Tisioneumonología ‘Prof. Dr. Raúl Vaccarezza’, Universidad de Buenos Aires; Argentina.
dc.descriptionFil: Cufré, Mónica. Instituto de Tisioneumonología ‘Prof. Dr. Raúl Vaccarezza’, Universidad de Buenos Aires; Argentina.
dc.descriptionFil: García, Ana. Instituto de Tisioneumonología ‘Prof. Dr. Raúl Vaccarezza’, Universidad de Buenos Aires; Argentina.
dc.descriptionFil: Gonzalez Montaner, Pablo. Instituto de Tisioneumonología ‘Prof. Dr. Raúl Vaccarezza’, Universidad de Buenos Aires; Argentina.
dc.descriptionFil: Ambroggi, Marta. Instituto de Tisioneumonología ‘Prof. Dr. Raúl Vaccarezza’, Universidad de Buenos Aires; Argentina.
dc.descriptionFil: Ritacco, Viviana. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.
dc.descriptionFil: van Soolingen, Dick. National Tuberculosis Reference Laboratory, National Institute for Public Health and the Environment, Bilthoven; Países Bajos.
dc.descriptionCurrent drug choices to treat extensively drug-resistant (XDR) tuberculosis (TB) are scarce; therefore, information on the safety, tolerability and efficacy of alternative regimens is of utmost importance. The aim of this study was to describe the management, drug adverse effects and outcome of alternative combined treatment in a series of XDR-TB patients.
dc.formatpdf
dc.languageen
dc.publisherOxford University Press
dc.relationThe Journal of antimicrobial chemotherapy
dc.rightsopen
dc.sourceJournal of Antimicrobial Chemotherapy 2012; 67(2):473-7.
dc.subjectTuberculosis
dc.subjectArgentina
dc.subjectLinezolid
dc.subjectMoxifloxacino
dc.subjectTioridazina
dc.titleSuccessful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine
dc.typeArtículo


Este ítem pertenece a la siguiente institución